Aspyre Lung enables robust variant calling in samples that fail next generation sequencing quality control

Molecular testing in non-small cell lung cancer (NSCLC) identifies patients likely to respond to targeted therapeutics. Panel-based testing often employs next-generation sequencing, but challenges include high sample failure rates, quality control issues, high tissue requirements and long turnaround...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Eleanor Ruth Gray, Ryan Thomas Evans, Elizabeth Gillon-Zhang, Katherine Elizabeth Knudsen, Kristine von Bargen, Julia Natalie Brown, Candace King, Cory Kiser, Mary Beth Rossi, Darren Davis, Michelle Lee Taylor, Jennifer Clower, Jian Yang, Cullen Taylor, Robert James Osborne, Jeffrey Gregg, Barnaby William Balmforth, Robert Wesley Snyder, Wendy Jo Levin, Elyse Shapiro
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2025-12-01
Cyfres:	Translational Oncology
Pynciau:	Molecular profiling Quality control Somatic variants Next-generation sequencing Precision oncology
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1936523325002967
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!